Blog / Legal News and Product Recalls

Nursing Home Overmedication

One of the most difficult decisions most families face at some point in their lives is having to place a loved one in a nursing home or other similar facility. Most of us will take on this challenge at some point and, as heart wrenching as it often is, sometimes there really is no other practical choice. For a family, that decision comes with tremendous responsibility to remain diligent in making certain that their loved ones are adequately fed, hydrated and regularly moved, to prevent bed sores that can easily lead to a terminal infection. Recently, through my own experiences, I've come to learn of another nursing home hazard to guard against, namely the possibility that our loved ones are being grossly overmedicated with drugs, being used off-label, to suppress the anxiety or aggression that can sometimes come with Alzheimer's disease and dementia. A 2011 study by the U.S. Department of Health and Human Resources found that found that 88 percent of Medicare claims for antipsychotics prescribed in nursing homes were for treating symptoms of dementia. The problem is that not only are antipsychotic drugs not approved to treat dementia, they come with a specific, black box warning that elderly patients with dementia-related psychosis who are treated with antipsychotic drugs are at an increased risk for heart failure, infections and death. Nevertheless, estimates by patient advocates reveal that approximately 300,000 nursing home residents nationwide continue to receive antipsychotic medications to "calm" their dementia-related symptoms. In recent years, substantial effort has been focused on this nationwide problem. In 2012, the federal Centers for Medicare and Medicaid Services ("CMS") undertook a concerted effort to reduce nursing home use of antipsychotic drugs, but missed their target. In 2013, Johnson & Johnson agreed to a $2.2 billion settlement of civil and criminal charges with the U.S. Department of Justice for its aggressive off-label marketing of antipsychotic drugs to nursing homes. Nevertheless, reduction in the overuse of these drugs in the nursing home setting has proven extremely difficult and, according to CMS, over 20 percent of long-stay nursing home residents continue to receive these drugs. What's even more alarming is that the residents receiving antipsychotics are not always the aggressive or difficult ones. One study, found that 22 percent of dementia residents on antipsychotics did not have any behavioral symptoms and 29.5 percent had non-aggressive behavioral symptoms. Another study revealed that antipsychotics were being used off-label in nursing homes to treat relatively benign behavioral symptoms such as wandering, crying or "resisting care." Although many nursing homes undoubtedly find it more convenient to manage resident anxiety, confusion, or behavioral issues with antipsychotics, this practice amounts to chemical restraint, plain and simple. It's really not much different than strapping a patient down for shock therapy but, given the well-developed body of research regarding the substantial risks to dementia patients subject to this practice, it is dangerous and misguided. Our loved ones deserve better, and there are alternatives. Residents often become agitated because they are in pain or discomfort. Simply giving them due attention, to identify and address those underlying causes, can make a substantial difference. In addition, evidence continues to mount showing that well-targeted, non-drug therapies, such as aromatherapy, music therapy, massage therapy, behavior management techniques, and animal-assisted therapy, can benefit dementia patients and help reduce certain behavioral issues. CMS studies have shown that changes promoting such therapies may be achievable without a substantial investment in additional resources and, when compared to the risks and costs of the off-label antipsychotics, these alternatives seem like a relative bargain. Although strides have been made towards reducing the practice of chemically restraining nursing home residents, this practice unfortunately remains relatively widespread today. Therefore, it continues to fall to those of us with parents, grandparents, friends or other relatives in such facilities to remain diligent in an effort to enhance the quality of life for our loved ones, to protect them from substandard care and to help promote goal-directed, person-centered care for each and every resident. Please take the time to learn about the type of medication your loved ones are being prescribed. Read the labels on that medication. If you feel a resident is being subjected to improper chemical restraint, speak up. Contact the director of nursing at the facility. Contact your loved one's doctor. If that doesn't work, report the practice to OHFLAC, the State agency that regulates nursing homes and other similar facilities, or contact an experienced attorney who can help get your loved one's life back on track and ensure the safest and best care for their particular circumstances.   One of the most difficult decisions most families face at some point in their lives is having to place a loved one in a nursing home or other similar facility. Most of us will take on this challenge at some point and, as heart wrenching as it often is, sometimes there really is no other practical choice. For a family, that decision comes with tremendous responsibility to remain diligent in making certain that their loved ones are adequately fed, hydrated and regularly moved, to prevent bed sores that can easily lead to a terminal infection. Recently, through my own experiences, I've come to learn of another nursing home hazard to guard against, namely the possibility that our loved ones are being grossly overmedicated with drugs, being used off-label, to suppress the anxiety or aggression that can sometimes come with Alzheimer's disease and dementia.
Posted in:

Related Posts

Hospital sign pointing to the Emergency Room and Main Entrance outside a medical building

$3.77 Million in Medical Malpractice Case Against Wheeling Doctor and PA

WHEELING, WV / PITTSBURGH, PA — An Ohio County, West Virginia jury has returned a $3.77 Million verdict in a medical malpractice case against a doctor and a physician’s assistant at WVU Medicine Wheeling Hospital. Following a four-day trial, the jury found both Dr. Barry Mitchell and Physician’s Assistant Michelle Porembka negligent in their medical care of 64 year old Julie Daley when she presented with abdominal complaints at the Wheeling Hospital emergency room in June 2022. As a result of the medical care providers’ failure to timely and properly treat her condition, Daley ultimately sustained a perforated colon along with necrosis which ultimately lead to her needing to have a permanent colostomy. The jury found that the conduct of both Mitchell and Poermbka fell below the standard of care for medical care providers in their field and that their negligence proximately caused injuries and damages to Mrs. Daley.  Daley was represented at trial by Geoff Brown and Tyler Smith of the Wheeling law firm of Bordas & Bordas. Following the verdict, Smith commented, “We are pleased that the jury recognized that this should not have happened to Julie Daley and that they compensated her for the life-long effects that she will have as a result of the negligence of the medical providers.” Mark Robinson and David Givens of Flaherty, Sensabaugh, and Bonasso represented the medical providers at trial.  Circuit Court Judge Jason Cuomo presided over the case. Brown stated “Our practice is based upon fighting for justice for people who have been injured or wronged by others.  Helping others is at the root of everything that we do and we are glad that we were able to help Julie and her family obtain a measure of justice through this case and this result.” About Bordas & Bordas Founded in 1985, Bordas & Bordas Attorneys PLLC has earned a reputation as one of the region’s premier personal injury and plaintiff litigation law firms. With offices in Wheeling and Moundsville, West Virginia; Pittsburgh, Pennsylvania; and St. Clairsville, Ohio, the firm represents clients in cases involving automobile and trucking accidents, medical malpractice, workplace injuries, nursing home negligence, product liability, wrongful death, insurance bad faith, and more. The firm operates on a contingency fee basis (clients pay only if there is a recovery) and offers free initial consultations. Rooted in its core values of experience, family, community, and results, Bordas & Bordas continues to stand as a trusted advocate for individuals and families across the Ohio Valley and beyond. Visit www.bordaslaw.com for more information.

The Pennsylvania Superior Court Analyzes the Federal Public Readiness and Emergency Preparedness Act in Denying Defendants’ Motion for Judgment on the Pleadings

The Pennsylvania Superior Court Analyzes the Federal Public Readiness and Emergency Preparedness Act in Denying Defendants’ Motion for Judgment on the Pleadings

The Pennsylvania Superior Court Analyzes the Federal Public Readiness and Emergency Preparedness Act in Denying Defendants’ Motion for Judgment on the Pleadings In Boyle v. Meyer, 2025 PA Super 198 (September 9, 2025), the Pennsylvania Superior Court denied a physical therapy company’s motion for judgment on the pleadings based on the immunity provisions contained in the federal Public Readiness and Emergency Preparedness Act (PREP Act). Background of the Case Plaintiff Boyle required physical therapy following open-heart surgery. To minimize the risk of contracting COVID-19, he arranged for OSPTA Home Care to provide in-home services. On November 8, 2020, physical therapist Meyer arrived without gloves, a face shield, or a proper mask — only wearing a thin, disposable surgical mask. Meyer also shook Boyle’s hand without gloves, did not wash her hands before treatment, and performed therapy as usual. Days later, OSPTA informed Boyle that Meyer had tested positive for COVID-19. Boyle soon developed symptoms, was hospitalized for ten days, and continued to suffer complications five months later. Boyle sued OSPTA and Meyer, alleging: Meyer was negligent in failing to wear proper personal protective equipment (PPE). Meyer exposed him to unreasonable risk and performed therapy despite known exposure. OSPTA failed to properly train and supervise Meyer and implement safeguards to prevent the virus’s spread. Defendants’ Motion and PREP Act Defense In response, Defendants admitted Meyer was not wearing gloves or a face shield but stated she wore a surgical mask and used hand sanitizer earlier in the day. They argued they were immune from liability under the Public Readiness and Emergency Preparedness Act, 42 U.S.C. §§ 247d-6d, 247d-6e. Defendants asserted that they met all four requirements for immunity: Public health emergency – The COVID-19 pandemic triggered PREP Act protections. Covered persons – They qualified as both “program planners” and “qualified persons” under the Act. Covered countermeasure – Meyer’s “thin, disposable surgical mask” was a device authorized for emergency use by the FDA. Causal relationship – Meyer’s use of the mask had a causal connection to Boyle’s COVID-19 claim. The trial court denied their motion for judgment on the pleadings. Superior Court’s Analysis On appeal, the Superior Court found several factual disputes that prevented judgment for the Defendants. Specifically: It was unclear whether Meyer’s surgical mask qualified as a “covered countermeasure.” The pleadings did not conclusively establish that the Defendants were “covered persons.” Even if both were true, PREP Act immunity applies only to the use or administration of a covered countermeasure — not to its non-use. Citing Hampton v. California, 83 F.4th 754 (9th Cir. 2023), the Court noted that the PREP Act shields defendants from claims related to administering a covered measure, but not from claims alleging failure to administer one. Because Boyle’s complaint focused on the failure to use proper PPE, inadequate screening, and lack of training, his claims fell outside the scope of federal immunity. Conclusion The Superior Court concluded that the PREP Act did not preempt Boyle’s state-law negligence claims, affirming the trial court’s denial of the motion for judgment on the pleadings. The full opinion in Boyle v. Meyer, 2025 PA Super 198 (September 9, 2025), is available on the Pennsylvania Judiciary website. To learn more about legal issues surrounding immunity and negligence in Pennsylvania courts, visit our post on how the PA Superior Court reviews evidentiary challenges in medical cases.

Lead Risk Prompts Nationwide Recall of Ground Cinnamon

Lead Risk Prompts Nationwide Recall of Ground Cinnamon

Lead Risk Prompts Nationwide Recall of Ground Cinnamon The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of 12 ground cinnamon brands after testing revealed elevated levels of lead. Roughly 21,690 units were sold through retailers like Dollar Tree and Save-A-Lot before being pulled from shelves. Consumers are urged to immediately throw away any affected products and avoid purchasing them until further notice. See the official FDA recall notice. Why This Recall Matters Although no injuries have been reported yet, the FDA warns that prolonged consumption of contaminated cinnamon can cause lead accumulation in the body. Children are especially at risk, since lead exposure can impact neurological development. Cinnamon is often used in foods like cereals, baked goods, and snack mixes — staples in many households with kids. This makes the recall a major public health concern for families nationwide, including those in West Virginia, Ohio, and Pennsylvania. FDA’s Broader Effort This recall is part of a larger FDA initiative to monitor imported spices more closely. Several cinnamon brands have been flagged in prior alerts, and surveillance is ongoing. For example: The FDA recently added Asli brand ground cinnamon to the list of affected products after new testing revealed unsafe lead levels. Additional products may be named as investigations continue. See the expanded FDA alert. What You Should Do If you purchased ground cinnamon recently: Check your spice cabinet against the recall list. Dispose of any recalled products immediately. Do not repurchase affected brands until the FDA clears them. If you suspect your child or another family member has been exposed, consult a healthcare provider for guidance. For ongoing updates, visit the FDA’s cinnamon recall page. Protecting Consumers This recall is a reminder that product safety issues extend beyond toys, appliances, and vehicles — even everyday food staples can carry risks. Families in WV, OH, and PA should stay informed about recalls and understand their rights if a defective or dangerous product causes harm. At Bordas & Bordas, our attorneys help consumers hold corporations accountable when safety takes a backseat to profit.